Viewing Study NCT03910712


Ignite Creation Date: 2025-12-26 @ 10:45 PM
Ignite Modification Date: 2026-02-24 @ 8:47 AM
Study NCT ID: NCT03910712
Status: UNKNOWN
Last Update Posted: 2019-04-10
First Post: 2019-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC
Sponsor: Peking Union Medical College Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module